Rucaparib for treating ovarian, fallopian tube or peritoneal cancer that has a BRCA mutation [ID1184]

Invitation to participate

• Final scope (PDF 242 KB)

  Published:

  17 July 2017

• NICE's response to comments on the draft scope and provisional matrix (PDF 298 KB)

  Published:

  17 July 2017

• Equality impact assessment (Scoping) (PDF 178 KB)

  Published:

  17 July 2017

• Final matrix (PDF 260 KB)

  Published:

  18 July 2017